San Diego, CA- headquartered illumina hosted the illumina Genomics Summit, on August 30, 2024 in Bangalore, India. It brought together over 200 leading genomics experts, clinicians, researchers, and scientists to discuss advancements in genomics and multiomics.
Joel Fellis, vice president of product management for next-generation sequencing (NGS), emphasized illumina’s focus on expanding the capabilities of NGS to provide deeper biological insights across genomics, epigenomics, transcriptomics, proteomics, and more.
Graeme Bethel, head of Strategic Growth for the AMEA region, discussed the global shift toward personalized healthcare and the widespread adoption of NGS in healthcare systems. He outlined the company’s corporate strategy and emphasized India’s crucial role in its success.
Bethel recognized illumina’s long-standing relationship of more than 18 years with the company’s channel partner in India, Premas Life Sciences.
The summit underscored the importance of expanding genomics access in India to address public health challenges.
The event featured distinguished guests, including keynote speaker Utpal Tatu from the prestigious Indian Institute of Science. A panel discussion on “Unlocking the Power of Genomics to Improve Human Health” included prominent figures from various healthcare and research institutions.
illumina’s commitment to India was further demonstrated by the recent opening of an office and Solutions Center in Bangalore, as well as a new Global Capability Center. The company plans to employ local professionals such as software engineers, IT hardware and network engineers, system analysts, data engineers, data analysts, configuration analysts, data stewards, procurement buyers, supply chain planners, business process analysts, quality engineers, and other roles by the end of 2025.
Gretchen Weightman, senior vice president of the Asia-Pacific, Middle East & Africa region said, “illumina has been supporting India for over a decade by providing access to genomic sequencing technologies, in particular next-generation sequencing, and building our presence and capability in India makes sense to accelerate this.”
Last updated: December 26th, 2025
